Tarceva and Capecitabine for Pancreatic Cancer

NCT00125021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Neoplasm Metastasis

Interventions

DRUG: Capecitabine
DRUG: OSI-774

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]